These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38438453)

  • 1. Electroencephalography-based classification of Alzheimer's disease spectrum during computer-based cognitive testing.
    Kim SK; Kim H; Kim SH; Kim JB; Kim L
    Sci Rep; 2024 Mar; 14(1):5252. PubMed ID: 38438453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography.
    Kim JG; Kim H; Hwang J; Kang SH; Lee CN; Woo J; Kim C; Han K; Kim JB; Park KW
    Sci Rep; 2022 Apr; 12(1):6219. PubMed ID: 35418202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
    Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of resting state EEG and structural MRI for classifying Alzheimer's disease and mild cognitive impairment.
    Farina FR; Emek-Savaş DD; Rueda-Delgado L; Boyle R; Kiiski H; Yener G; Whelan R
    Neuroimage; 2020 Jul; 215():116795. PubMed ID: 32278090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
    Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
    Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    Meghdadi AH; Stevanović Karić M; McConnell M; Rupp G; Richard C; Hamilton J; Salat D; Berka C
    PLoS One; 2021; 16(2):e0244180. PubMed ID: 33544703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An attention-based deep learning approach for the classification of subjective cognitive decline and mild cognitive impairment using resting-state EEG.
    Sibilano E; Brunetti A; Buongiorno D; Lassi M; Grippo A; Bessi V; Micera S; Mazzoni A; Bevilacqua V
    J Neural Eng; 2023 Feb; 20(1):. PubMed ID: 36745929
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectral and complexity analysis of scalp EEG characteristics for mild cognitive impairment and early Alzheimer's disease.
    McBride JC; Zhao X; Munro NB; Smith CD; Jicha GA; Hively L; Broster LS; Schmitt FA; Kryscio RJ; Jiang Y
    Comput Methods Programs Biomed; 2014 Apr; 114(2):153-63. PubMed ID: 24598317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memorization Test and Resting State EEG Components in Mild and Subjective Cognitive Impairment.
    Mazzon G; De Dea F; Cattaruzza T; Manganotti P; Monti F; Accardo A
    Curr Alzheimer Res; 2018; 15(9):809-819. PubMed ID: 29701152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Verbal Fluency Strategies among Individuals with Normal Cognition, Amnestic and Non-Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Bairami S; Folia V; Liampas I; Ntanasi E; Patrikelis P; Siokas V; Yannakoulia M; Sakka P; Hadjigeorgiou G; Scarmeas N; Dardiotis E; Kosmidis MH
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893577
    [No Abstract]   [Full Text] [Related]  

  • 12. Gradual Disturbances of the Amplitude of Low-Frequency Fluctuations (ALFF) and Fractional ALFF in Alzheimer Spectrum.
    Yang L; Yan Y; Wang Y; Hu X; Lu J; Chan P; Yan T; Han Y
    Front Neurosci; 2018; 12():975. PubMed ID: 30618593
    [No Abstract]   [Full Text] [Related]  

  • 13. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Network Properties Across Preclinical Stages of Alzheimer's Disease Using a Visual Short-Term Memory and Attention Task with High-Density Electroencephalography: A Brain-Connectome Neurophysiological Study.
    Lazarou I; Georgiadis K; Nikolopoulos S; Oikonomou VP; Stavropoulos TG; Tsolaki A; Kompatsiaris I; Tsolaki M;
    J Alzheimers Dis; 2022; 87(2):643-664. PubMed ID: 35367964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of the "Cognitive" Brain Wave P3b at Rest for Alzheimer Dementia Prediction in Mild Cognitive Impairment.
    Porcaro C; Vecchio F; Miraglia F; Zito G; Rossini PM
    Int J Neural Syst; 2022 May; 32(5):2250022. PubMed ID: 35435134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Region and frequency specific changes of spectral power in Alzheimer's disease and mild cognitive impairment.
    Roh JH; Park MH; Ko D; Park KW; Lee DH; Han C; Jo SA; Yang KS; Jung KY
    Clin Neurophysiol; 2011 Nov; 122(11):2169-76. PubMed ID: 21715226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Individuals With Mild Cognitive Impairment Using Working Memory-Induced Intra-Subject Variability of Resting-State EEGs.
    Trinh TT; Tsai CF; Hsiao YT; Lee CY; Wu CT; Liu YH
    Front Comput Neurosci; 2021; 15():700467. PubMed ID: 34421565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference between subjective and objective cognitive decline confirmed by power spectral density.
    Jeong HT; Youn YC; Park KY; Choi BS; Nam TK; Sung HH
    Cogn Neuropsychiatry; 2024 May; 29(3):194-207. PubMed ID: 39068667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness of memory deficits in subjective cognitive decline, mild cognitive impairment, Alzheimer's disease and Parkinson's disease.
    Lehrner J; Kogler S; Lamm C; Moser D; Klug S; Pusswald G; Dal-Bianco P; Pirker W; Auff E
    Int Psychogeriatr; 2015 Mar; 27(3):357-66. PubMed ID: 25382659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connectome-based model predicts episodic memory performance in individuals with subjective cognitive decline and amnestic mild cognitive impairment.
    Zhu Y; Zang F; Wang Q; Zhang Q; Tan C; Zhang S; Hu T; Qi L; Xu S; Ren Q; Xie C
    Behav Brain Res; 2021 Aug; 411():113387. PubMed ID: 34048872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.